Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
G

Medication Dispensing and Administration Error Leads to Resident Death

Garden Grove, California Survey Completed on 11-04-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to provide appropriate pharmaceutical services to meet the needs of a resident, resulting in a significant medication error. The pharmacy dispensed conventional amphotericin B instead of the prescribed amphotericin B liposomal (AmBisome), which are different formulations with distinct dosing requirements. The physician's order specified amphotericin B liposomal 350 mg in 250 ml D5W to be administered over two hours, but the pharmacy delivered seven vials of amphotericin B 50 mg each, along with a 250 ml bag of D5W. The medication delivered did not match the physician's order, and the packaging included a warning that the maximum daily dose should not exceed 1.5 mg/kg, which was not observed. The nurse (RN) who administered the medication did not recognize the difference between the two formulations and prepared the entire 350 mg dose of amphotericin B in 250 ml D5W, administering it at a rate of 125 ml/hr. This resulted in the resident receiving over three times the maximum recommended dose of amphotericin B, at a concentration and rate higher than recommended by the manufacturer. The nurse did not double-check the medication label against the physician's order, nor did he research the medication prior to administration, despite the packaging containing a clear warning about dosing limits. The nurse also stated this was the first time he had administered amphotericin B and did not notice the discrepancy in medication names. The resident, who had a history of mucormycosis, respiratory failure, a tracheostomy, and was ventilator dependent, experienced a rapid deterioration in condition shortly after the infusion began and was found without a pulse a few hours later. The pharmacy's Chief Compliance Officer confirmed the error in dispensing and noted that the medication was not labeled with a high alert warning as required for high-risk medications. The Director of Nursing acknowledged that the nurse did not follow the facility's policy for verifying the right medication and dose prior to administration.

An unhandled error has occurred. Reload 🗙